47.85
전일 마감가:
$47.64
열려 있는:
$47.5
하루 거래량:
47,273
Relative Volume:
0.36
시가총액:
$2.10B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.24%
1개월 성능:
+8.60%
6개월 성능:
+577.76%
1년 성능:
+0.00%
Anbio Biotechnology Stock (NNNN) Company Profile
NNNN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
NNNN
Anbio Biotechnology
|
47.85 | 2.09B | 0 | 0 | 0 | 0.00 |
![]()
ISRG
Intuitive Surgical Inc
|
466.86 | 162.93B | 9.15B | 2.63B | 1.99B | 7.17 |
![]()
BDX
Becton Dickinson Co
|
192.39 | 54.82B | 21.39B | 1.61B | 2.55B | 5.56 |
![]()
RMD
Resmed Inc
|
277.05 | 40.09B | 5.15B | 1.40B | 1.65B | 9.51 |
![]()
ALC
Alcon Inc
|
80.17 | 39.01B | 10.03B | 1.07B | 1.39B | 2.17 |
![]()
WST
West Pharmaceutical Services Inc
|
250.73 | 17.80B | 2.96B | 487.70M | 344.00M | 6.68 |
Anbio Biotechnology 주식(NNNN)의 최신 뉴스
Visual trend scoring systems applied to Puma Biotechnology Inc.Trade Volume Summary & Fast Exit Strategy with Risk Control - Newser
Is AMZE showing signs of accumulationEarnings Overview Report & Real-Time Buy Zone Alerts - Newser
Sentiment Turns Positive on ASGN Incorporated — Reversal AheadWeekly Stock Report & Daily Momentum Trading Reports - beatles.ru
Is Climb Bio Inc. showing signs of accumulation2025 Trade Ideas & High Conviction Investment Ideas - Newser
Are Bears Losing Grip on BLFS? getLinesFromResByArray error: size == 0 - 더경남뉴스
Analyzing Share Issuance and Voting Rights Dynamics in Growth-Stage Biotechs: Navigating Governance and Dilution Risks - AInvest
What earnings revisions data tells us about iBio Inc.2025 Big Picture & Real-Time Chart Breakout Alerts - Newser
LKY(linkey) Project ReviewTrade Exit Summary & Safe Entry Zone Identification - Newser
Is ACCESS Newswire Inc. forming a bottoming base2025 Year in Review & Expert Verified Movement Alerts - Newser
Real time breakdown of Graham Holdings Company stock performance2025 Breakouts & Breakdowns & Growth Oriented Trading Recommendations - Newser
Is ZVIA stock poised for growthDollar Strength & Free High Accuracy Swing Entry Alerts - Newser
Technical signs of recovery in Fortive Corporation2025 Big Picture & Technical Entry and Exit Alerts - Newser
How High Can FHE(mind network) Go2025 EndofYear Setup & Safe Entry Zone Tips - Newser
Will Grayscale Ethereum Trust outperform the marketJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Live market analysis of HJJ CLMarket Movement Recap & Verified Technical Signals - Newser
Top Reasons to Buy PIX(pixelswap)July 2025 Weekly Recap & Capital Efficiency Focused Ideas - Newser
What recovery options are there for RGC Resources Inc.Market Growth Review & Fast Exit and Entry Trade Guides - Newser
Arista Networks Volume Dives 27.46 to 97th Rank Amid Record Earnings and Analyst Upgrades - AInvest
Why Rapid7 Inc. stock attracts strong analyst attention2025 Sector Review & Risk Adjusted Buy/Sell Alerts - Newser
Is Greenland Technologies Holding Corporation’s ROE strong enoughRate Hike & Weekly High Conviction Trade Ideas - sundaytimes.kr
Should you hold or exit HONE nowLayoff News & Accurate Buy Signal Notifications - Newser
Can machine learning forecast TMUS recoveryEarnings Beat & Technical Buy Zone Confirmation - Newser
How do analysts view the current valuation of Nasdaq stocks? - AInvest
News impact scoring models applied to Cmb.Tech NVWall Street Watch & Daily Profit Focused Screening - Newser
How to read the order book for STRRPMarket Movers & Real-Time Chart Breakout Alerts - Newser
Leading vs lagging indicators on ETI.PR performanceFed Meeting & High Accuracy Swing Entry Alerts - Newser
The Unlocking of Voting Control in Anbio Biotechnology: A Post-Lock-Up Opportunity in a Dual-Class IPO - AInvest
Anbio Biotechnology's Post-Lock-Up Investment Implications: Unlocking Shareholder Value and Market Dynamics - AInvest
Anbio Biotechnology Class A Ordinary Shares Subject to Lock-Up Agreement Ending August 18, 2025. - AInvest
Certain Class B Ordinary Shares of Anbio Biotechnology are subject to a Lock-Up Agreement Ending on 18-AUG-2025. - MarketScreener
Can MNTK expand its profit marginsMarket Trend Review & AI Forecasted Stock Moves - thegnnews.com
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
CompanyInsider Selling & Reliable Breakout Stock Forecasts - Newser
Zhengye Skyrocketed 33.84%—What’s Fueling This Biotech Breakout? - AInvest
Will The Southern Company Preferred Security benefit from macro trendsMulti-Year Signal Summary and Entry Timing - Newser
enCore Energy Corp. stock prediction for this weekFree ROI Boosting Trade Opportunity Calendar - Newser
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - digitalmore.co
Elegoo Launches Nexprint Million-Dollar Creator Fund to Reward Original Content - digitalmore.co
Anbio Biotechnology's Strategic Expansion into Point-of-Care Diagnostics: A High-Growth Opportunity in Global Infectious Disease Management - AInvest
Breakthrough: Anbio's 15-Minute PCR System and Chikungunya Test Transform Disease Detection - Stock Titan
Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewswire Inc.
Why Coherus BioSciences Inc. stock attracts strong analyst attentionSummary of Trade Cycles in 5-Year Range - Newser
Full technical analysis of AFSC stockEarnings Based Stock Performance Forecast - Newser
Anbio Biotechnology (NNNN) Surges 13% in Dramatic Intraday Rally – What’s Fueling the Momentum? - AInvest
7 healthtech scaleups to watch in Europe & UK in 2025 - Tech Funding News
Is FORR stock bottoming outCapital Growth Plan for New Investors - Newser
Will Intuitive Machines Inc. stock recover after recent dropIntraday Movement Recap and Chart Summary - Newser
IRBT stock daily chart insightsDownside Control Plan With Support Analysis - Newser
Why UGRO stock attracts strong analyst attentionFree Early Entry Tips With Low Risk Zone - Newser
BAC.PRCC stock prediction for this weekFree Smart Money Tracking Signal Generator - Newser
Price momentum metrics for Iterum Therapeutics plc explainedEarly Entry Ideas with Momentum Potential - Newser
Anbio Biotechnology (NNNN) 재무 분석
Anbio Biotechnology (NNNN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):